Medication info

Dapagutine Tablet 5mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Shinpoong Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/box (7 tablets/Alu-Alu*4), 28 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202200980 · Approved 2022.03.08

This product's status changed to Approval withdrawn on 2024.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Shinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication helps patients with type 2 diabetes effectively control their blood sugar while following dietary and exercise regimens. It can be used alone or in combination with other diabetes medications. It can be safely used by patients with type 2 diabetes who have cardiovascular disease or risk factors, but it is advisable to refer to a healthcare professional for related precautions. This drug improves blood sugar control and aids in maintaining cardiovascular health, thereby enhancing diabetes management.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when administered in combination with metformin, the recommended initial dose of this medicine is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This drug should not be used in patients who have had an allergic reaction to the active ingredient or excipients, in patients with type 1 diabetes, or in patients undergoing dialysis. Care should be taken when used in patients with decreased fluid volume or poor kidney function, as hypotension or worsening kidney function may occur, so conditions should be carefully monitored before and after administration. The blood sugar control effect of this drug varies according to kidney function, so it is not recommended for patients with severely impaired kidney function. The most common side effect is genital infection, which may occur more frequently in women or patients with a history of infection, requiring caution. Hypoglycemic symptoms may appear, so especially when used with medications such as insulin or sulfonylureas, blood sugar changes should be closely monitored. Dehydration or symptoms of hypotension due to decreased body fluid may occur, so elderly patients or those taking diuretics should be particularly cautious. Severe metabolic disorder, known as diabetic ketoacidosis, may occur, so if related symptoms appear, immediate consultation with medical staff is required. Serious urinary infections such as urinary tract infection and pyelonephritis may occur, so prompt treatment is necessary if infection symptoms are present. The safety of this drug has not been sufficiently established for patients with severely impaired liver function, so caution is needed. Pregnant or breastfeeding women should avoid using this medication, and treatment should be discontinued immediately upon confirmation of pregnancy. For children, the safety and effectiveness of this drug have not been established, thus use is not recommended. In cases of overdose, there are no specific antidotes, so treatment should be symptomatic and follow medical staff instructions. Finally, this drug should be stored in its original container and kept out of reach of children.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, elevated hematocrit, decreased initial renal creatinine clearance, dyslipidemia, increased initial serum creatinine, elevated blood urea, weight loss, acute pyelonephritis, rash, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, intestinal perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, paresthesia, cerebral infarction, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, asthenia, pain, ligament sprain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylaxis, chest pain, chest discomfort, fatigue, edema, foreign body sensation, facial edema, facial pain, warmth, influenza-like symptoms, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, xerosis, allergic dermatitis, contact dermatitis, diabetic foot ulcer, excessive sweating eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, flank pain, fibromyalgia, limb discomfort, muscle cramps, musculoskeletal discomfort, osteopenia, contusions, road traffic accidents, drug overdose, ankle fracture, orbital fracture, foot fracture, gastrointestinal foreign body, hand fracture, pelvic fracture, laceration, ligament rupture, limb injury, meniscus injury, skin abrasion, tendon rupture, thoracic vertebra fracture, tibia fracture, dental injury, dry eye, ocular pain, retinal disorder, vision impairment, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, diplopia, eyelid edema, keratitis, glaucoma, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sputum, sleep apnea syndrome, wheezing, arteriosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, palpitations, anxiety disorder, nocturia, hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, dizziness, tinnitus, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, hemoptysis, sputum, sleep apnea syndrome, wheezing

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that is tightly sealed to avoid exposure to air or moisture and should be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box (7 tablets/Alu-Alu*4), 28 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.